药明生物（02269）3月4日公布2026年2月股份变动月报。公告显示，截至2026年2月28日，公司注册股本合计6,000,000,000股普通股（面值0.000008333333美元），对应注册股本总额50,000美元，保持与上月末一致。
公告披露，公司已发行股份数量为4,137,541,236股，报告期内未发生新增发行、回购或注销，也无库存股变动。本月无期权行使，未获得新发行股份，相关激励计划均保持稳定。因此，公司股本结构截至2月底未发生变化。
根据公告，药明生物确认截至本月末已满足香港联交所主板上市规则的最低公众持股量要求。公告由董事陈智胜签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.